Breasr Cancer Report 2013

Embed Size (px)

Citation preview

  • 7/27/2019 Breasr Cancer Report 2013

    1/47

  • 7/27/2019 Breasr Cancer Report 2013

    2/47

    BREAST CANCER

    Breast cancer is a malignant tumor that starts

    in the cells of the breast.

    A malignant tumor is a group of cancer cells

    that can grow into (invade) surrounding

    tissues or spread (metastasize) to distantareas of the body.

  • 7/27/2019 Breasr Cancer Report 2013

    3/47

    The disease occurs almost entirely in women,

    but men can get it, too.

    One of every 13 Filipino women are expected todevelop breast cancer in her lifetime. (Philippine

    Star, 2013)

    Breast cancer is the most common cancer in thePhilippines, taking at least 16 percent of the

    50,000 cases diagnosed. (Department of Health

    and Philippine Cancer Society, 2010)

    In men , less than 1% of all breast cancers.(Dr.

    Aldine Basa, 2010)

  • 7/27/2019 Breasr Cancer Report 2013

    4/47

    The Normal

    Breast

  • 7/27/2019 Breasr Cancer Report 2013

    5/47

    The Lymphatic

    System of the Breast

  • 7/27/2019 Breasr Cancer Report 2013

    6/47

  • 7/27/2019 Breasr Cancer Report 2013

    7/47

    Pathogenesis of Breast Cancer

    Normal cells in the body communicate with

    each other and regulate each other's

    proliferation (division).Cells proliferate toreplace worn-out cells.

    When cancer occurs, cells escape the normalcontrols on their growth and proliferation.

  • 7/27/2019 Breasr Cancer Report 2013

    8/47

    How do cells escape their normal

    growth and proliferation?

    By acquiring damage (mutations) to genes

    that normally regulate cell proliferation.

  • 7/27/2019 Breasr Cancer Report 2013

    9/47

    What are the genes that are being

    damaged?

    Tumor Suppressor Genes

    they control the processes of cell growth and cell

    death (called apoptosis).

    Proto-oncogenes

    responsible for promoting cell growth.

  • 7/27/2019 Breasr Cancer Report 2013

    10/47

    What happens to the genes when

    mutated?

    Tumor Suppressor Genes (acquired/inherited)

    this can lead to tumor formation or growth

    Proto-oncogenes (acquired)

    they become oncogenes and then can promote

    tumor formation or growth.

  • 7/27/2019 Breasr Cancer Report 2013

    11/47

    Two Categories of Breast Cancer

    Noninvasive Breast Cancer

    Ductal Carcinoma in Situlocated within the ductand have not invaded the surrounding fatty breasttissue.

    Lobular Carcinoma in Situabnormal cells growinside the lobules of the breast, but have not spreadto the nearby tissue or beyond.

    Invasive Breast Cancer

    Infiltrating Ductal Carcinomaoriginates in themammary glands and grows in the epithelial cells

    lining these ducts.

  • 7/27/2019 Breasr Cancer Report 2013

    12/47

    Possible Outcomes of Metastasis of

    Breast Cancer

    70% of breast cancer patients suffer from

    bone metastases.

    10% suffer from brain metastases. 20% suffer from lung and liver metastases.

  • 7/27/2019 Breasr Cancer Report 2013

    13/47

    Manifestation of Metastases

    Metastatic breast cancer to the lung or pleura

    causes

    chronic cough,

    dyspnea

    abnormal chest X-ray

    chest pain

  • 7/27/2019 Breasr Cancer Report 2013

    14/47

    Manifestation of Metastases

    Metastatic disease to the bone causes

    severe,

    progressive pain

    less commonly

    pathological fracture

    erythema over the affected bone

    swelling

  • 7/27/2019 Breasr Cancer Report 2013

    15/47

    Manifestation of Metastases

    Metastatic breast cancer to the brain causes

    the following symptoms:

    persistent,

    progressively worsening headache,

    visual changes,

    seizures, nausea or vomiting,

    vertigo,

    behavioral and personality changes,

    increased intracranial pressure.

  • 7/27/2019 Breasr Cancer Report 2013

    16/47

    Manifestation of Metastases

    Metastatic disease to the liver causes

    Jaundice

    elevated liver enzymes

    abdominal pain

    loss of appetite

    nausea

    vomiting

  • 7/27/2019 Breasr Cancer Report 2013

    17/47

  • 7/27/2019 Breasr Cancer Report 2013

    18/47

    Gender

    Simply being a woman is the main risk factor

    for developing breast cancer.

    Men can develop breast cancer, but thisdisease is about 100 times more common

    among women than men.

    This is likely because men have less of thefemale hormones estrogen and progesterone,

    which can promote breast cancer cell growth

  • 7/27/2019 Breasr Cancer Report 2013

    19/47

    Aging

    Your risk of developing breast cancer

    increases as you get older.

    About 1 out of 8 invasive breast cancers arefound in women younger than 45, while

    about 2 of 3 invasive breast cancers are

    found in women age 55 or older.

  • 7/27/2019 Breasr Cancer Report 2013

    20/47

  • 7/27/2019 Breasr Cancer Report 2013

    21/47

  • 7/27/2019 Breasr Cancer Report 2013

    22/47

    Race and Ethnicity

    Overall, White women are slightly more likely todevelop breast cancer than are African-Americanwomen, but African-American women are more

    likely to die of this cancer. However, in women under 45 years of age, breast

    cancer is more common in African-American

    women. Asian, Hispanic, and Native-American women

    have a lower risk of developing and dying frombreast cancer.

  • 7/27/2019 Breasr Cancer Report 2013

    23/47

    Dense Breast Tissue

    Women with dense breasts is four to five

    times more likely to get breast cancer than

    women with less dense breasts.

  • 7/27/2019 Breasr Cancer Report 2013

    24/47

    P lif i l i i h i I h

  • 7/27/2019 Breasr Cancer Report 2013

    25/47

    Proliferative lesions with atypia: In these

    conditions, there is an overgrowth of cells in

    the ducts or lobules of the breast tissue, withsome of the cells no longer appearing normal.

    They have a stronger effect on breast cancerrisk, raising it 3 1/2 to 5 times higher than

    normal.

  • 7/27/2019 Breasr Cancer Report 2013

    26/47

    Menstrual periods

    Women who have had more menstrual cycles

    because they started menstruating early

    (before age 12) and/or went through

    menopause later (after age 55) have a slightly

    higher risk of breast cancer.

    The increase in risk may be due to a longer

    lifetime exposure to the hormones estrogen

    and progesterone.

  • 7/27/2019 Breasr Cancer Report 2013

    27/47

    Having children

    Women who have had no children or who had

    their first child after age 30 have a slightly

    higher breast cancer risk.

  • 7/27/2019 Breasr Cancer Report 2013

    28/47

    Hormone Therapy and Birth Control

    Pills

    Women using this therapeutic regimens can

    increase the risk of developing breast cancer

    due to the prolonged exposure of estrogen

    and progesterone.

  • 7/27/2019 Breasr Cancer Report 2013

    29/47

    Alcohol

    Alcohol causes cancer cells' blood vessels to

    grow which in turn fuels the growth of the

    tumor, a process known as angiogenesis.

  • 7/27/2019 Breasr Cancer Report 2013

    30/47

    Overweight and Obese

    Most of a woman's estrogen comes from fat

    tissue. Having more fat tissue especially after

    menopause can increase your chance of

    getting breast cancer by raising the estrogen

    levels.

  • 7/27/2019 Breasr Cancer Report 2013

    31/47

    Tobacco Smoking

    For a long time, studies found no link between

    cigarette smoking and breast cancer.

    In 2009, the International Agency for Research on

    Cancer concluded that there is limited evidence that

    tobacco smoking causes breast cancer.

    It is Suggestive but not Sufficient evidence

    of a link at this point. (The 2006 US Surgeon

    General's report, The Health Consequences of

    Involuntary Exposure to Tobacco Smoke)

  • 7/27/2019 Breasr Cancer Report 2013

    32/47

  • 7/27/2019 Breasr Cancer Report 2013

    33/47

    Other possible signs and symptoms: Swelling of all or part of a breast (even if no distinct

    lump is felt)

    Skin irritation or dimpling Breast or nipple pain

    Nipple retraction (turning inward)

    Redness, scaliness, or thickening of the nipple or breastskin

    Nipple discharge (other than breast milk)

    Lymph nodes under the arm

    .

  • 7/27/2019 Breasr Cancer Report 2013

    34/47

    Early Cancer Detection Women age 40 and older should have a

    mammogram every year and should continueto do so for as long as they are in good health.

    Women in their 20s and 30s should have aclinical breast exam (CBE) as part of a periodic(regular) health exam by a health professionalpreferably every 3 years. Starting at age 40,women should have a CBE by a healthprofessional every year.

  • 7/27/2019 Breasr Cancer Report 2013

    35/47

    Early Cancer Detection Breast self-examination (BSE) is an option for

    women starting in their 20s. Women shouldbe told about the benefits and limitations ofBSE. Women should report any breast

    changes to their health professional rightaway.

    Women at high risk (greater than 20% lifetimerisk) should get an MRI and a mammogramevery year.

  • 7/27/2019 Breasr Cancer Report 2013

    36/47

    Nursing Diagnosis

    Deficient knowledge related to planned surgicaltreatments.

    Anxiety related to the diagnosis of cancer

    Fear related to specific treatments and bodyimage changes

    Risk for ineffective coping related to the diagnosis

    of breast cancer Decisional conflict related to treatment options.

    Disturbed body image related to loss or alteration

    of the breast

  • 7/27/2019 Breasr Cancer Report 2013

    37/47

    Screening Procedures

    Self-Breast Examination

    Clinical Breast Examination

    Mammogram

  • 7/27/2019 Breasr Cancer Report 2013

    38/47

    Diagnostic exams in Breast CABiopsy

    It is the examination of affected tissue in detectingpresence of cancer cells.

    Nuclear Magnetic Resonance Imaging

    This is viewing the structure of the breast using a high tech

    radiation imaging in detecting presence of mass or tumors.

    Ductogram

    A type of X-ray that helps determine the cause of nipple

    discharge. A ductogram can show if there is a mass inside

    the duct at the nipple

  • 7/27/2019 Breasr Cancer Report 2013

    39/47

    Treatment

    Lumpectomy

    Partial or segmental mastectomy

    Simple mastectomy

    Modified radical mastectomy Axillary lymph node dissection

    Chemotherapy

    Radiation Therapy

  • 7/27/2019 Breasr Cancer Report 2013

    40/47

    Surgical Nursing Intervention

    Pre-operative Obtain informed consent

    Provide good care for a breast care

    Be sure to know what kind of surgery to beperformed in order to prepare the patient

    If mastectomy is scheduled:

    Prevent pulmonary complications andthromboembolism

    Place patient on the affected side

  • 7/27/2019 Breasr Cancer Report 2013

    41/47

    Surgical Nursing Intervention

    Post-operative Inspect dressing anteriorly and posteriorly

    Check circulatory status

    Encourage coughing exercises and turning scheduleevery two hours

    Provide psychological and emotional support

    Explain to the patient that she may experience phantom

    breast syndrome

  • 7/27/2019 Breasr Cancer Report 2013

    42/47

    Nursing Interventions Monitor for adverse effects of radiation therapy such as

    fatigue, sore throat, dry cough, nausea, anorexia.

    Monitor for adverse effects of chemotherapy; bonemarrow suppression, nausea and vomiting, alopecia,

    weight gain or loss, fatigue, stomatitis, anxiety, anddepression.

    Realize that a diagnosis of breast cancer is a devastating

    emotional shock to the woman. Provide psychologicalsupport to the patient throughout the diagnostic andtreatment process.

    Involve the patient in planning and treatment.

  • 7/27/2019 Breasr Cancer Report 2013

    43/47

    Nursing Interventions Describe surgical procedures to alleviate fear.

    Prepare the patient for the effects of chemotherapy, and planahead for alopecia, fatigue.

    Administer antiemetics prophylactically, as directed, forpatients receiving chemotherapy.

    Administer I.V. fluids and hyperalimentation as indicated.

    Help patient identify and use support persons or family orcommunity.

    Suggest to the patient the psychological interventions may benecessary for anxiety, depression, or sexual problems.

    Teach all women the recommended cancer-screeningprocedures.

  • 7/27/2019 Breasr Cancer Report 2013

    44/47

    Medications

    Trastuzumab (Herceptin) Pertuzumab (Perjeta)

    Ado-trastuzumab emtansine

    (KadcylaLapatinib (Tykerb)

    Bevacizumab (Avastin)

  • 7/27/2019 Breasr Cancer Report 2013

    45/47

  • 7/27/2019 Breasr Cancer Report 2013

    46/47

  • 7/27/2019 Breasr Cancer Report 2013

    47/47